This biopharmaceutical company has 14 marketed products and over 4200 employees on four continents. Gilead had almost $8 billion in revenues in 2010.
Gilead Sciences consistently ranks among top performers in the Wealth Creation Index. Among the consistent top performers, Mike Burdi, Applied Finance Group senior analyst, finds a common thread: “Do your customers care whether you stay in business? It’s one thing to say that one is customer-focused; most claim to be as a matter of course. But would your customers really miss not having access to what you offer?” For Gilead customers, that answer is yes.
| Score | 2010 Score | % Change In Score | Market Value/Invested Capital | Three-Year EM | EM Change | Mgmt Quality |
|---|---|---|---|---|---|---|
| 92.8 | 86.7 | 7.0% | B | A | A | A |
A careless misunderstanding of the relationship between revenue and growth leads most organizations to operate…
Fewer CEOs expect business conditions to improve over the next 12 months, as more move…
The method doesn’t matter. What matters is that you, the leader, are explicit about what…
It’s not just about pricing. U.S.-based producers can differentiate themselves by delivering greater overall value.
The question isn't whether disruption is coming for your business, it's whether you've built the…
When noise drives the news, a disciplined response is key. A framework for CEOs.